Chemoinformaics analysis of Bicyclovetivenol
| Molecular Weight | 220.356 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 4 |
| Exact Molecular Weight | 220.183 | nRing | 3 |
| Solubility: LogS | -4.497 | nHRing | 0 |
| Solubility: LogP | 5.383 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.375 |
| Synth | 2.735 |
| Natural Product Likeliness | 1.927 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.983 |
| Pgp-sub | 0.011 |
| HIA | 0.006 |
| CACO-2 | -4.496 |
| MDCK | 0.0000215 |
| BBB | 0.411 |
| PPB | 0.933982 |
| VDSS | 5.091 |
| FU | 0.0581161 |
| CYP1A2-inh | 0.964 |
| CYP1A2-sub | 0.335 |
| CYP2c19-inh | 0.851 |
| CYP2c19-sub | 0.818 |
| CYP2c9-inh | 0.915 |
| CYP2c9-sub | 0.876 |
| CYP2d6-inh | 0.24 |
| CYP2d6-sub | 0.125 |
| CYP3a4-inh | 0.6 |
| CYP3a4-sub | 0.232 |
| CL | 7.617 |
| T12 | 0.383 |
| hERG | 0.024 |
| Ames | 0.001 |
| ROA | 0.005 |
| SkinSen | 0.963 |
| Carcinogencity | 0.078 |
| EI | 0.887 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.028 |
| Antiviral | Yes |
| Prediction | 0.877598 |